The 3D genome structure is also disrupted in endocrine-resistant ER+ breast cancer cells6,7, notably through long-range chromatin changes at ER-enhancer binding sites that are DNA hypermethylated in resistant cells7. Here, ESR1 is linked to breast carcinoma.